Novel Oral Anti-Obesity Agents: New Perspectives with Lorcaserin?

被引：0
|
作者：
Baptist Gallwitz
机构：
[1] Eberhard-Karls-University,Department of Medicine IV
来源：
Drugs | 2013年 / 73卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：393 / 395
页数：2
相关论文
共 50 条
  • [1] Novel Oral Anti-Obesity Agents: New Perspectives with Lorcaserin?
    Gallwitz, Baptist
    DRUGS, 2013, 73 (05) : 393 - 395
  • [2] Lorcaserin and phentermine exert anti-obesity effects with modulation of the gut microbiota
    Song, Eun-Ji
    Shin, Na Rae
    Jeon, Songhee
    Nam, Young-Do
    Kim, Hojun
    FRONTIERS IN MICROBIOLOGY, 2023, 13
  • [3] The utility of animal models to evaluate novel anti-obesity agents
    Vickers, Steven P.
    Jackson, Helen C.
    Cheetham, Sharon C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (04) : 1248 - 1262
  • [4] New Obesity Agents: Lorcaserin and Phentermine/Topiramate
    Fleming, Joshua W.
    McClendon, Katie S.
    Riche, Daniel M.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (7-8) : 1007 - 1016
  • [5] Pyrazoles as Potential Anti-Obesity Agents
    Kumar, Gupta Girish
    Vikas, Kumar
    Vinod, Kumar
    RESEARCH JOURNAL OF CHEMISTRY AND ENVIRONMENT, 2011, 15 (03): : 90 - 103
  • [6] Centrally acting anti-obesity agents
    Hepworth, David
    Carpino, Philip A.
    Black, Shawn C.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 41, 2006, 41 : 77 - 97
  • [7] Food Ingredients as Anti-Obesity Agents
    Saito, Masayuki
    Yoneshiro, Takeshi
    Matsushita, Mami
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2015, 26 (11): : 585 - 587
  • [8] Novel anti-obesity drugs
    Proietto, J
    Fam, BC
    Ainslie, DA
    Thorburn, AW
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (06) : 1317 - 1326
  • [9] Novel anti-obesity drugs
    Tripp, B
    Ludvik, B
    ACTA MEDICA AUSTRIACA, 2004, 31 (04) : 133 - 138
  • [10] Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications
    Halpern, Bruno
    Halpern, Alfredo
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (02) : 305 - 315
12345